Applied Pharma Research s.a. products

Prescription Healthcare Products

NEXODYN - AcidOxidizing Solution

Nexodyn® AcidOxidizing Solution (AOS) is the Tehclo™ based wound care solution proven to restart healing in stalled wounds.2,6 A wealth of evidence and real-world experience consistently show accelerated closure1 with reduced infection rates1 and less wound-associated pain2. So make Nexodyn® AOS a fundamental part of your wound bed preparation routine.

Ondansetron - Prevention and Treatment of Chemo and Radiotherapy

Ondansetron is indicated for the prevention and treatment of chemo- and radiotherapy induced nausea and vomiting (CINV and RINV), and for the prevention and treatment of post-operative nausea and vomiting (PONV). Has been Developed by APR in cooperation with MonoSol Rx for the USA market and Labtec TESA outside USA respectively. The ODF technology aims to get around administration problems of the drug and improve patient compliance.

PKU GOLIKE KRUNCH - Practical and Flexible Protein Substitute

PKU GOLIKE KRUNCH is the new practical and flexible protein substitute that helps patients be more comfortable with taking their amino acid mix.

Hailey Hailey Disease (HHD)

APR TD012 is a clinical stage drug candidate for the treatment of wounds in Hailey Hailey Disease (HHD) patients. The product improves healing process thanks to its bioburden control and its anti-oxidant properties.Oxidative stress has been demonstrated to play a specific role in the pathogenesis of HHD by regulating the expression of factors playing an important role in keratinocyte proliferation and differentiation. Preliminary pre-clinical data suggest that our product could be able to shift the oxidation reduction (redox) balance, leading to a protective antioxidant response. In addition, thanks to Hypochlorous acid (HClO) presence APR-TD012 could exert a strong antimicrobial activity inactivating one of the most common causes of skin infections in the HHD lesions, which is Staphylococcus aureus.